Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 04-2002 | 03-2002 | 01-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,122 | 51 | -1,488 | 711 | -9,083 |
| Depreciation Amortization | 100 | 198 | 53 | 880 | 524 |
| Income taxes - deferred | N/A | -19 | N/A | -138 | N/A |
| Accounts receivable | 66 | 122 | -9 | 557 | 52 |
| Accounts payable and accrued liabilities | -281 | -54 | 213 | -455 | -271 |
| Other Working Capital | -199 | -747 | -838 | 318 | 40 |
| Other Operating Activity | 933 | -56 | -182 | -98 | 1,457 |
| Operating Cash Flow | $-3,503 | $-505 | $-2,251 | $1,775 | $-7,281 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,542 | N/A | -2,711 | N/A | -5,293 |
| PPE Investments | N/A | -211 | N/A | -617 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -22 |
| Sale Of Investment | 5,310 | N/A | 5,293 | N/A | 4,613 |
| Purchase Sale Intangibles | -54 | N/A | -29 | N/A | -218 |
| Other Investing Activity | -54 | 0 | -29 | 0 | -218 |
| Investing Cash Flow | $2,714 | $-211 | $2,553 | $-617 | $-920 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -255 | N/A | -530 | N/A |
| Common Stock Issued | 34 | N/A | 64 | N/A | 8,147 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -560 |
| Other Financing Activity | 946 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $980 | $-255 | $64 | $-530 | $7,587 |
| Beginning Cash Position | 3,107 | 1,705 | 3,107 | 1,077 | 3,721 |
| End Cash Position | 3,298 | 734 | 3,473 | 1,705 | 3,107 |
| Net Cash Flow | $191 | $-971 | $366 | $628 | $-614 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,503 | -505 | -2,251 | 1,775 | -7,281 |
| Capital Expenditure | N/A | -211 | N/A | -617 | N/A |
| Free Cash Flow | -3,503 | -716 | -2,251 | 1,158 | -7,281 |